Shares in major pharmaceutical companies also dipped. For example: Eli Lilly shares fell 4.9 percent Pfizer 4.5 percent Amgen nearly 4.3 percent Novo Nordisk 3.4 percent The announcement sparked alarm ...
↘️ Applied Materials (AMAT): Shares fell 8% after the semiconductor-equipment company posted a weaker-than-expected sales ...
The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
A research team in China has held atoms in a state of quantum superposition for 23 minutes, suggesting tantalizing new ...
A roundup of top health news highlights Novo Nordisk's $16.5 billion deal scrutiny, Amgen's weight-loss drug controversy, ...
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback